In: Guidelines for the Management of Transfusion-Dependent β-Thalassaemia (TDT) [Internet]. 5th edition. Nicosia, Cyprus: Thalassaemia International Federation; 2025. Chapter 2.
1 Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
2 Transfusion Research Unit, Public Health and Preventive Medicine, Monash University, Melbourne; Department of Haematology, Monash Health, Clayton, Australia
3 Campus of Haematology Franco and Piera Cutino, UOC Ematologia e Malattie Rare, Centro ERN, Centro HUB for Thalassemia and Haemoglobinipathy, AOOR Villa Sofia-V. Cervello, Palermo, Italy
Book Affiliations
1 Professor of Internal Medicine, Hematology & Oncology; Associate VP for Academic Centers, Development and External Affairs; Director, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon
2 Associate Professor, Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens Medical School, Athens, Greece
3 Professor of Haematology (Emeritus) and Consultant Haematologist, University College London Hospitals, London, United Kingdom
4 Professor of Medicine, Unit of Medicine and Metabolic Disease, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
5 Group Chief Research Officer (Burjeel Holdings) and Founding Director, Center for Research on Rare Blood Disorders (CR-RBD), Burjeel Medical City, Abu Dhabi, United Arab Emirates; Adjunct Professor, Department of Public Health & Epidemiology, Khalifa University, Abu Dhabi, United Arab Emirates; Adjunct Professor, Division of Hematology/Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA